GASTRIC ADENOCARCINOMA WITH PERITONEAL METASTASIS

Clinical trials for GASTRIC ADENOCARCINOMA WITH PERITONEAL METASTASIS explained in plain language.

Never miss a new study

Get alerted when new GASTRIC ADENOCARCINOMA WITH PERITONEAL METASTASIS trials appear

Sign up with your email to follow new studies for GASTRIC ADENOCARCINOMA WITH PERITONEAL METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

New cocktail of drugs targets Hard-to-Treat stomach cancer

Disease control Recruiting now

This phase 2 trial is testing a combination of four drugs—cadonilimab, LM-302, S-1, and paclitaxel—in 40 people with a specific type of advanced stomach cancer (Claudin 18.2-positive) that has spread to the lining of the abdomen. The drugs are given through a vein and directly in…

Matched conditions: GASTRIC ADENOCARCINOMA WITH PERITONEAL METASTASIS

Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC

GASTRIC ADENOCARCINOMA WITH PERITONEAL METASTASIS

Get alerted when new GASTRIC ADENOCARCINOMA WITH PERITONEAL METASTASIS trials appear

New cocktail of drugs targets Hard-to-Treat stomach cancer